CFLT vs ERNA · rev $963.6M vs P/E 0.0, rev $582.0K
Confluent Inc (CFLT) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
Confluent Inc (CFLT) is a software - infrastructure company listed on US.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported CFLT revenue for 2024-12-31 was $963.6M. Net income was -$345.1M. Revenue was up 24.0% from 2023-12-31 to 2024-12-31. CFLT currently screens at market cap $11.13B.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
CFLT currently screens at market cap $11.13B. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the CFLT and ERNA stock pages for the full models.
Not investment advice.